Voyxact, an APRIL inhibitor, receives FDA accelerated approval for adults with primary IgA nephropathy to reduce proteinuria.

The Buckland Group launched Quvara Medical as the newest CDMO to debut this year after buying a former Becton Dickinson manufacturing site in the U.K. for an undisclosed price. | The Buckland Group ...

The addition of a new 300mg presentation allows for greater dosing flexibility to ease overall treatment burden and discomfort. The interchangeable biosimilar was originally approved in March 2025 in ...

A family outing to a mall in New Hampshire turned in an instant when a child picked up a syringe that was laying in the middle of the floor. WBZ-TV's Brandon Truitt reports. Trump Makes Prediction ...

A family outing to a mall in New Hampshire turned in an instant when a child picked up a syringe that was laying in the middle of the floor. WBZ-TV's Brandon Truitt reports. Opinion: Jen Psaki is ...